| GENEED, INC. RELEASES DRUG SAFETY:
ADVERSE EVENT REPORTING COURSE
-Learning Course Next Release in GeneEd’s Regulatory and
Compliance (GxP) Program -
San Francisco, CA, February 6, 2007 – GeneEd,
Inc., a leading provider of Continuing Medical Education (CME) accredited
online learning for the life-science and healthcare professions, announced
today the release of a Drug Safety: Adverse Event Reporting course.
The course discusses the reasons and mechanisms for adverse event collection
during and following clinical studies. Key concepts and roles are defined
and current and legacy terminologies used to report adverse events (AEs)
in clinical trials are discussed. In addition, the reporting responsibilities
of the sponsor and investigator are explored on both a national and global
scale.
“Our Drug Safety: Adverse Event Reporting course arms industry
professionals and investigating physicians with needed information to
understand the adverse events reporting process,” Alycia Shilton-Lloyd,
GeneEd’s chief scientific officer, said. “Patient safety today
is of paramount importance during clinical trials and once a medication
is marketed. Accurate and timely reporting of potential adverse drug reactions,
through a rigorous adverse event reporting process, is mandated by regulatory
agencies to ensure protection of patients' safety and rights, and we believe
our course will enable industry professionals to optimize patient safety
and data collection.”
Individual students interested in the “Drug Safety—Adverse
Event Reporting” course can register on the GeneEd website at http://www.geneed.com,
and corporate clients can inquire about bulk registration at sales@geneed.com.
This is one of a seven course e-learning Regulatory and Compliance (GxP)
curriculum. Upcoming courses in this series will include “Introduction
to GxP,” and “The Global Regulatory Environment.”
ABOUT GENEED, INC. – GeneEd is an e-learning provider
for the biopharmaceutical industry, with several clients whom are Fortune
500 companies. The company’s CME courses span the entire pharmaceutical
development pipeline and healthcare-education spectrum. The GeneEd Regulatory
and Compliance courses provide GxP training for clinical sites, CRAs,
and management. For more information regarding this, or any other programs
offered by GeneEd, please contact Alycia Shilton-Lloyd or visit: www.geneed.com.
.
Main Web site: www.geneed.com
E-mail: info@geneed.com
(Flash is a trademark of Macromedia Corp/Adobe Inc.)
|
